Tumor cytotoxicity induced by modulators of the CXCR4 receptor
    2.
    发明授权
    Tumor cytotoxicity induced by modulators of the CXCR4 receptor 有权
    由CXCR4受体的调节剂诱导的肿瘤细胞毒性

    公开(公告)号:US07312305B2

    公开(公告)日:2007-12-25

    申请号:US10392324

    申请日:2003-03-20

    IPC分类号: C07K4/02

    CPC分类号: A61K38/162

    摘要: The present invention provides a means of selectively killing epithelial cell carcinomas by administering a CXCR4-specific sequence of the Gp120 protein or Nef proteins or the proteins themselves (the modulators) such as that found in strains HIV-1, HIV-2, SIV, or FIV CXCR4-specific Gp 120 sequences or Nef proteins or sequences may be delivered to the mucosa or systemically. The mucosal means of application include oral, intranasal, ocular, intravaginal, rectal, and/or intraurethral administration in liquid or particulate form.

    摘要翻译: 本发明提供了通过施用Gp120蛋白或Nef蛋白或本发明的蛋白质(调节剂)的CXCR4特异性序列,例如在菌株HIV-1,HIV-2,SIV中发现的选择性杀死上皮细胞癌的方法, 或FIV CXCR4特异性Gp120序列或Nef蛋白或序列可以递送至粘膜或全身。 粘膜使用方法包括液体或颗粒形式的口服,鼻内,眼部,阴道内,直肠和/或尿道内给药。